Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
Completed
Conditions studied: Hepatitis C Virus
In brief
Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.
Key facts
- Study ID
- NCT00819026
- Run by
- University of Wisconsin, Madison
- People needed
- 15
- Starts
- 2008-10-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2014-12-10
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HCV infected on immunosuppression
Where it is running
- University of Wisconsin — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.